"Genetic Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Techniques and strategies which include the use of coding sequences and other conventional or radical means to transform or modify cells for the purpose of treating or reversing disease conditions.
Descriptor ID |
D015316
|
MeSH Number(s) |
E02.095.301 E05.393.420.301
|
Concept/Terms |
Genetic Therapy- Genetic Therapy
- Genetic Therapies
- Therapies, Genetic
- Therapy, Genetic
- Therapy, DNA
- DNA Therapy
Genetic Therapy, Somatic- Genetic Therapy, Somatic
- Genetic Therapies, Somatic
- Somatic Genetic Therapies
- Somatic Genetic Therapy
- Therapies, Somatic Genetic
- Therapy, Somatic Genetic
Genetic Therapy, Gametic- Genetic Therapy, Gametic
- Gametic Genetic Therapies
- Gametic Genetic Therapy
- Genetic Therapies, Gametic
- Therapies, Gametic Genetic
- Therapy, Gametic Genetic
|
Below are MeSH descriptors whose meaning is more general than "Genetic Therapy".
Below are MeSH descriptors whose meaning is more specific than "Genetic Therapy".
This graph shows the total number of publications written about "Genetic Therapy" by people in this website by year, and whether "Genetic Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 0 | 1 |
2000 | 1 | 1 | 2 |
2001 | 1 | 0 | 1 |
2003 | 2 | 1 | 3 |
2004 | 0 | 2 | 2 |
2005 | 1 | 0 | 1 |
2006 | 2 | 1 | 3 |
2007 | 1 | 2 | 3 |
2008 | 1 | 0 | 1 |
2009 | 1 | 2 | 3 |
2010 | 1 | 0 | 1 |
2011 | 1 | 1 | 2 |
2013 | 1 | 1 | 2 |
2014 | 2 | 0 | 2 |
2015 | 2 | 1 | 3 |
2016 | 4 | 0 | 4 |
2017 | 28 | 16 | 44 |
2018 | 38 | 22 | 60 |
2019 | 13 | 9 | 22 |
2020 | 6 | 1 | 7 |
2021 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Genetic Therapy" by people in Profiles.
-
Development of COVID-19 vaccines utilizing gene therapy technology. Int Immunol. 2021 09 25; 33(10):521-527.
-
Combination therapy with onasemnogene and risdiplam in spinal muscular atrophy type 1. Muscle Nerve. 2021 10; 64(4):487-490.
-
Direct reprogramming induces vascular regeneration post muscle ischemic injury. Mol Ther. 2021 10 06; 29(10):3042-3058.
-
COVID-19 and Liver Cirrhosis: Focus on the Nonclassical Renin-Angiotensin System and Implications for Therapy. Hepatology. 2021 08; 74(2):1074-1080.
-
High-Resolution Imaging of Human Viruses in Liquid Droplets. Adv Mater. 2021 Sep; 33(37):e2103221.
-
SARS-CoV-2 research using human pluripotent stem cells and organoids. Stem Cells Transl Med. 2021 11; 10(11):1491-1499.
-
Gene therapies and COVID-19 vaccines: a necessary discussion in relation with viral vector-based approaches. Orphanet J Rare Dis. 2021 07 16; 16(1):316.
-
Intranasal gene therapy to prevent infection by SARS-CoV-2 variants. PLoS Pathog. 2021 07; 17(7):e1009544.
-
COVID-19-related autoimmune disorders of central nervous system (CRAD-C): Is it a new entity? Autoimmun Rev. 2021 Sep; 20(9):102888.
-
Immune Responses to Recombinant Adenoviruses As Gene Therapy Vectors and COVID-19 Vaccines: A Two-Edged Sword. Hum Gene Ther. 2021 07; 32(13-14):645-646.